Affordable Access

Publisher Website

Silencing MRP4 by small interfering RNA reverses acquired DDP resistance of gastric cancer cell

Authors
Journal
Cancer Letters
0304-3835
Publisher
Elsevier
Publication Date
Volume
291
Issue
1
Identifiers
DOI: 10.1016/j.canlet.2009.10.003
Keywords
  • Gastric Cancer
  • Mrp4
  • Multi-Drug Resistance
  • Chemotherapy
  • Ddp
Disciplines
  • Biology

Abstract

Abstract A cisplatin (DDP) resistant cell line (SGC7901/DDP) from a Chinese gastric cancer cell line (SGC7901) was established by step-increasing DDP treatment, and the resultant cell line showed an over 21.9-fold increased resistance to DDP. To identify the mechanism of DDP resistance, the differential gene expression panel was examined by Affymetrix microarray. Among the identified differential genes, 681 genes expression were increased and 1139 genes were decreased. To confirm these gene changes furtherly, one of the upregulated gene, MRP4 was identified with increased mRNA and protein level of SGC7901/DDP by RT-PCR and Western-blot analysis compared with its parental cell line. By using the small interfering RNA (RNAi) to decrease the MRP4 expression, the DDP resistance phenotype of SGC7901/DDP was reversed. These data suggest that MRP4 is a DDP resistance candidate gene of SGC7901 gastric cancer cell line.

There are no comments yet on this publication. Be the first to share your thoughts.